SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing intense market volatility as investors weigh a strong earnings beat against the uncertainty surrounding the announced leadership transition of CEO Shantanu Narayen. The community is actively debating the company's long-term viability in an AI-driven market, with some seeing the current pullback as a deep-value buying opportunity while others fear increasing competition from generative AI tools will diminish its software moat.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is facing significant investor skepticism as the stock languishes near all-time lows, with community discourse heavily divided between those betting on long-term growth and acquisition potential versus frustrated bears concerned about share dilution and intense competition. While sentiment is fueled by robust ARR growth and cybersecurity demand, investors are actively debating the impact of AI-driven tools on the company's competitive moat and future guidance.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is facing significant selling pressure as investors struggle with valuation concerns and sector-wide weakness, despite strong earnings reports and bullish community sentiment regarding the company's long-term AI-driven cybersecurity potential. Traders remain divided, with some actively accumulating shares at lower price levels while others express frustration over algorithmic trading and ongoing stock dilution.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is currently capturing attention as investors weigh the company's significant equity stakes in firms like Babcock & Wilcox against concerns over short-selling reports and the upcoming annual report filing. While the community is actively debating the potential for a short squeeze and the impact of debt restructuring, discussions remain polarized between those betting on a deep-value turnaround and those wary of ongoing regulatory scrutiny.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is rallying as investors react to the departure of a high-level FDA official previously perceived as a significant barrier to regulatory approvals in the rare disease space. The community is increasingly bullish, citing positive pivotal data and strong anticipation for the company's upcoming late-breaking presentation at a major medical conference as key drivers for potential rapid regulatory progress.

Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.

Ulta Beauty Inc

Ulta Beauty is experiencing heightened volatility following a recent quarterly earnings report where mixed guidance fueled intense debate among retail traders. The community is actively discussing the company's long-term competitive position against rivals like Sephora and the broader impact of consumer spending shifts on specialty retail.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is seeing heightened volatility and downward pressure following the release of Google's 'Project Genie' prototype, which has stoked investor fears regarding AI competition in the gaming sector. While the community remains sharply divided, with bears pointing to regulatory and safety concerns and bulls highlighting the stock's oversold conditions, traders are closely watching the upcoming earnings report for signs of a turnaround.

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.

Elicio Therapeutics Inc.

Elicio Therapeutics Inc

Elicio Therapeutics is trending as the community closely monitors the progress of its Phase 2 AMPLIFY-7P trial, with investors highlighting the company's potential to address unmet needs in KRAS-mutant cancers. Discussions frequently center on the clinical efficacy of its ELI-002 cancer vaccine, with many participants speculating on its valuation arbitrage potential and its status as a compelling acquisition target in the biotechnology sector.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing increased investor activity as the community anticipates potential government contracts related to national security and domestic pharmaceutical manufacturing, particularly following recent management updates and sector-wide interest in reshoring supply chains. Enthusiastic shareholders are actively discussing the company's strong cash position and its strategic pivot into specialized materials, viewing the current stock consolidation as a potential accumulation phase ahead of upcoming earnings and future policy catalysts.

PagerDuty, Inc. engages in the provision of a digital operations management platform. Its products include incident management, automation, status pages, integrations, artificial intelligence for information technology operations (AIOps), customer service operations, and stakeholders’ communications. The firm's solutions include incident management transformation, operations center modernization, automation standardization, customer experience operations, digital operations resiliency, scaled service ownership, and remote-location operations. It also serves the financial services, healthcare, non-profit, public sector, and retail industries. The company was founded by Andrew Miklas, Baskar Puvanathasan, and Dan Alexandru Solomon in 2009 and is headquartered in San Francisco, CA.

Pagerduty Inc

PagerDuty is currently trending as investors debate the stock's valuation and potential for M&A, with many in the community highlighting the disconnect between the company's profitability and its suppressed share price. While some are frustrated by recent performance and technical trends, others remain optimistic about its long-term viability, consistently pointing to its balance sheet, cash position, and the possibility of a buyout as key catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook 

Cooper Companies tops Q1 EPS estimates and lifts FY26 outlook as MyDay and MiSight drive growth. Shares slip despite solid margin expansion.

Pacific Biosciences of California (NASDAQ:PACB) Receives Underweight Rating from Barclays

Barclays reissued an "underweight" rating and issued a $1.50 price objective on shares of Pacific Biosciences of California in a research report on Friday...

Christian Henry Sells 12,497 Shares of Pacific Biosciences of California (NASDAQ:PACB) Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Christian Henry sold 12,497 shares of the company's stock in a transaction that occurred on Tuesday, March 3rd. The...

Clover Health Enters Collaboration to Be Part of CMS Aligned Network

CLOV jumped 8% after partnering with Kno2 to become the first payer live on a CMS Aligned Network, enabling real-time patient access to clinical and claims data.

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

CAH shares have surged 49% in six months as strong pharma distribution, expanding specialty services and fast-growing adjacencies fuel Cardinal Health???s earnings outlook.

Pacific Biosciences of California, Inc. $PACB Shares Sold by ARK Investment Management LLC

ARK Investment Management LLC decreased its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 14.8% during the 3rd quarter, according to the company in its most...

Pacific Biosciences of California (NASDAQ:PACB) Insider Christian Henry Sells 12,497 Shares

Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) insider Christian Henry sold 12,497 shares of the firm's stock in a transaction that occurred on Tuesday, March 3rd. The shares...

Here's Why You Should Retain Revvity Stock in Your Portfolio for Now

RVTY gains from strong diagnostics demand and fast-growing Signals software, but China policy pressure and weak research spending temper near-term growth.

Intuitive Surgical Expands Direct Operational Presence in Europe

ISRG expands in Europe after acquiring da Vinci and Ion distribution across Italy, Spain and Portugal, integrating operations to directly support customers.

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub

PACB teams with DNAstack to launch a global HiFi genome network, linking 10,000+ sequences to boost rare disease research without moving data.

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Current Price	$1.27
Prev Close	$1.35
Open	$1.30
Dividend Yield	0.00%
50-Day Moving Average	$1.91
Beta	2.06
Avg. Volume	6.72M
PE Ratio	-0.74

52-Week High	$2.73
52-Week Low	$0.8511
Market Capitalization	$407.7M
EPS (Annual)	-$1.82
Price to Book	76.23
Revenue Per Employee	$329,907.22

PACB
Pacific Biosciences of California Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PACB News

PACBPacific Biosciences of California Inc